As for brain tumors, in a previous study, the mRNA of RPS27 was 6.2- and 8.8-fold (mean) enhanced in gliomas of WHO grades II and III with (p < 0.01) and without IDH mutation (p = 0.01), respectively, compared with that in the normal healthy brain. Here, RPS27 is linked to central nervous system cancer.